Abstracts Archive - Page 1088 of 2425 - ACR Meeting Abstracts

Abstract Number: 1251 • 2018 ACR/ARHP Annual Meeting
Guideline Adherence for Perioperative Use of Immunosuppressive Medications in Patients with Rheumatologic Disease
Grace Berlin, Carolyn Casey, Susan Kim and James Ross, Rheumatology, Lehigh Valley Health Network, Allentown, PA
Background/Purpose: In response to the lack of clear data to dictate recommendations for use of DMARDs and biologic therapy in the perioperative period, The American…
Abstract Number: 1252 • 2018 ACR/ARHP Annual Meeting
Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience
Karim Ladak¹, Ting Pan² and Catherine MacLean¹, ¹Rheumatology, Hospital For Special Surgery, New York, NY, ²Value Office, Hospital For Special Surgery, New York, NY
Background/Purpose: Tumor necrosis factor inhibitors (TNFi) revolutionized treatment of various conditions, however they drastically increase the risk of latent tuberculosis (LTBI) reactivation. Many national medical…
Abstract Number: 1253 • 2018 ACR/ARHP Annual Meeting
Lipid Screening and Treatment Patterns Among Patients with Rheumatic Diseases
Alexander Peck¹, Gilbert Ortega², Jawad Bilal³, Ella Starobinska², Phan Saligrama² and Dominick Sudano⁴, ¹Division of Internal Medicine, University of Arizona College of Medicine, Tucson, AZ, ²Internal Medicine, University of Arizona, Tucson, Tucson, AZ, ³Internal Medicine, University of Arizona, Tucson, AZ, ⁴University of Arizona Arthritis Center, University of Arizona, Tucson, AZ
Background/Purpose: The importance of lipid management is well recognized in rheumatic diseases. In fact, annual cardiovascular risk assessment is especially recommended for individuals with rheumatoid…
Abstract Number: 1254 • 2018 ACR/ARHP Annual Meeting
QI Project: Inpatient Practices in Ordering Fluorescent Anti-Nuclear Antibodies (F-ANA) and ANA Subserologies in a City Hospital in an Underserved Community
Ivan Emil Ramirez de Oleo¹, Beverly Johnson^2,3 and Barbara Mendez-Agrusa⁴, ¹Internal Medicine, Jacobi Medical Center, Bronx, NY, ²Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, ³Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ⁴Medicine, Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: It is important for internists to know how to appropriately and effectively order subspecialty labs. As part of the choosing wisely campaign in 2013,…
Abstract Number: 1255 • 2018 ACR/ARHP Annual Meeting
Elevated Serum Globulin Gap As a Reliable and Cost-Savings Marker of Inflammation in Patients with Systemic Rheumatic Diseases
William Stohl¹, Beatrice Kenol², Andrew Kelly², Aditi Ananth Correa² and Richard Panush³, ¹Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, ²Keck School of Medicine of University of Southern California, Los Angeles, CA, ³Rheumatology, Keck School of Medicine of University of Southern California, Los Angeles, CA
Background/Purpose: In clinical practice, the two most commonly used markers of systemic inflammation are the serum CRP level and ESR. The economic costs of these…
Abstract Number: 1256 • 2018 ACR/ARHP Annual Meeting
A Customized Health Information Technology Effectively Identifies and Directs Bone Health Services in Rural Veterans with Osteoporosis Risk Factors
Shardool Patel¹, Zachary L. Anderson¹, Grant W. Cannon², Brian C. Sauer² and Karla L. Miller², ¹Salt Lake City VA Medical Center, Salt Lake City, UT, ²Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT
Background/Purpose: Osteoporosis is underdiagnosed and undertreated in the Veterans Health Administration (VHA), especially in rural Veterans. Tools to identify risk factors in Veterans are available.…
Abstract Number: 1257 • 2018 ACR/ARHP Annual Meeting
Simple and Cost-Effective Intervention Doubled the Rate of Osteoporosis Screening in High Risk Rheumatology Patients
Mosaab Mohameden¹, Victoria Malkhasyan², Adam Shurbaji¹ and Candice Yuvienco³, ¹Internal Medicine, University of California San Francisco - Fresno Medical Education Program, Fresno, CA, ²University of California San Francisco - Fresno Medical Education Program, Fresno, CA, ³Internal Medicine, Division of Rheumatology Director, University of California San Francisco - Fresno Medical Education Program, Division of Rheumatology Director, Fresno, CA
Background/Purpose: Osteoporosis is a common bone disorder that places patients at risk of pathologic fractures. Osteoporotic fractures can be devastating and associated with significant morbidity,…
Abstract Number: 1258 • 2018 ACR/ARHP Annual Meeting
Can Patients Enter Medical History Data By Self-Report Directly into an Electronic Medical Record (EMR)? “Private Medical History” (PMH) Software for Physician Report in EMR Format and Patient Storage to Correct and Update Medical History for Any EMR
Theodore Pincus¹, Ricardo Gomez Lara² and Niels Steen Krogh³, ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²of ZiteLab ApS, Frederiksberg, Denmark, ³ZiteLab ApS, Copenhagen, Denmark
Background/Purpose: The electronic medical record (EMR) promised greater efficiencies in clinical medicine. This goal may be met in part in an ICU, operating room, and…
Abstract Number: 1259 • 2018 ACR/ARHP Annual Meeting
Driving Performance and Safety in Rheumatoid Arthritis: A Systematic Review
Daniel Zhou¹, Ted R. Mikuls², Cynthia Schmidt³, Bryant R. England⁴, Debra A Bergman⁵, Matthew Rizzo⁶, Jennifer Merickel⁶ and Kaleb Michaud^7,8, ¹Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, ³McGoogan Library of Medicine, University of Nebraska Medical Center, Omaha, NE, ⁴Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, ⁵Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, ⁶Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, ⁷Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁸FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS
Background/Purpose: Automobile driving represents an instrumental activity of daily living (IADL). Symptoms accompanying RA, including fatigue, joint pain and stiffness, decreased strength, reduced mobility, and…
Abstract Number: 1260 • 2018 ACR/ARHP Annual Meeting
Predictors of Hospitalization Due to Acute Gout: A Retrospective Cohort Study
Nadine Mbuyi¹, Isha Shah², Steven Reinert³, Grayson Baird⁴, Pieusha Malhotra⁵, Ross Hilliard⁶ and Deepan Dalal⁷, ¹Rheumatology, The Warren Alpert Medical School of Brown University, Providence, RI, ²Internal Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, ³Lifespan Information Services, Lifespan Information Services, Providence, RI, Providence, RI, ⁴Department of Biostatistics, Lifespan, Rhode Island Hospital, Providence, RI, ⁵Rheumatology, Roger William Medical Center, Providence, RI, Providence, RI, ⁶Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, ⁷Medicine/Rheumatology, The Warren Alpert Medical School of Brown University, Providence, RI
Background/Purpose: Despite effective treatments, hospitalization due to acute gout is increasing and is financially burdensome. Prior studies have primarily attributed the increased rate of gout…
Abstract Number: 1261 • 2018 ACR/ARHP Annual Meeting
Development a Core Domain Set to Assess Shared Decision Making Interventions in Rheumatology: An OMERACT White Paper to Facilitate Endorsement
Karine Toupin-April¹, Jennifer Barton^2,3, Liana Fraenkel⁴, Alexa Meara⁵, Linda Li⁶, Peter Brooks⁷, Maarten de Wit⁸, Dawn Stacey^9,10, France Légaré¹¹, Beverly Shea^9,12,13, Anne Lyddiatt¹⁴, Catherine Hofstetter¹⁵, Robin Christensen¹⁶, Marieke Scholte-Voshaar^17,18, Maria Suarez-Almazor¹⁹, Annelies Boonen²⁰, Tanya Meade^21,22, Lyn March²², Janet Elizabeth Jull⁹, Willemina Campbell²³, Rieke Alten²⁴, Suvi Karuranga²⁵, Esi Morgan²⁶, Jessica Kaufmann²⁷, Sophie Hill²⁷, Lara J. Maxwell^9,10, Dorcas Beaton²⁸, Yasser El-Miedany²⁹, Shikha Mittoo³⁰, Susan J. Bartlett³¹, Jasvinder A. Singh³² and Peter Tugwell³³, ¹Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ²VA Portland Health Care System, Portland, OR, ³Oregon Health & Science University, Portland, OR, ⁴Yale University School of Medicine, New Haven, CT, ⁵Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, ⁶Arthritis Research Canada, Richmond, BC, Canada, ⁷The University of Melbourne, Victoria, Australia, ⁸EULAR standing committee of PARE, Zurich, Switzerland, ⁹University of Ottawa, Ottawa, ON, Canada, ¹⁰The Ottawa Hospital Research Institute, Ottawa, ON, Canada, ¹¹Université Laval, Montreal, QC, Canada, ¹²Bruyere Research Institute, Ottawa, ON, Canada, ¹³School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, ON, Canada, ¹⁴Musculoskeletal Group, Cochrane Collaboration, Hamilton, ON, Canada, ¹⁵OMERACT patient research partner group, Ottawa, ON, Canada, ¹⁶Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, ¹⁷University of Twente, Enschede, ON, Netherlands, ¹⁸OMERACT patient research partner group, Enschede, Netherlands, ¹⁹Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, ²⁰Department of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands, Maastricht, Netherlands, ²¹Western Sydney University, New South Wales, Australia, ²²University of Sydney, New South Wales, Australia, ²³OMERACT patient research partner group, Toronto, ON, Canada, ²⁴University Medicine Berlin, Berlin, Germany, ²⁵Access to Medicine Foundation, Haarlem, Netherlands, ²⁶University of Cincinnati, Cincinnati, OH, ²⁷La Trobe University, Victoria, Australia, ²⁸Mobility Program Clinical Research Unit, St Michael's Hospital, Toronto, ON, Canada, ²⁹Ain Shams University, Cairo, Egypt, ³⁰Involved medicine, Toronto, ON, Canada, ³¹Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³²Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³³Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada
Background/Purpose: Shared decision making (SDM) improves decisional outcomes and patient-physician communication and holds great potential for improving the management of various rheumatology conditions. However, the…
Abstract Number: 1262 • 2018 ACR/ARHP Annual Meeting
The Importance of Standardization of Musculoskeletal Procedures Performed in an Academic Rheumatology Clinic
Sarah Ifteqar¹, Ricky Mehta¹, Paul Schmidt² and Mehrdad Maz³, ¹Allergy, Clinical Immunology and Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, ²Allergy, Clinical Immunology, & Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, ³Allergy, Clinical Immunology, and Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
Background/Purpose: Diagnostic and therapeutic arthrocentesis and soft tissue injections are routinely performed by Rheumatologists mostly in the outpatient and some in the inpatient settings. There…
Abstract Number: 1263 • 2018 ACR/ARHP Annual Meeting
Develop a Master Algorithm for Drug Withdraw Strategy in Reduction of Adverse Events – a Machine Learning Model from the Smart System of Disease Management (SSDM)
Yan Zhao¹, Jing Yang², Jianlin Huang³, Hua Wei⁴, Yongfu Wang⁵, Rong Mu⁶, Xiaoxia Zuo⁷, Hongzhi Wang⁸, Xinwang Duan⁹, Jing Xue¹⁰, Hongsheng Sun¹¹, Bin Wu¹², Lirong Kang⁵, Feng Wei¹³, Cundong Mi¹⁴, Yanping Zhao¹⁵, Yang Li¹⁶, Haiying Chen¹⁷, Zhenbin Li¹⁸, Qingliang Meng¹⁹, Yuhua Jia²⁰, Hui Xiao²⁰ and Fei Xiao²⁰, ¹Rheumatology, Peking Union Medical College Hospital, Beijing, China, ²Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, ³Department of rheumatology, The Sixth Hospital Affiliated to Sun yat-sen University, Guangzhou, China, ⁴Northern Jiangsu People's Hospital, Yangzhou, China, ⁵The First Affiliated Hospital of BaoTou Medical College, Baotou, China, ⁶Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, ⁷Xiangya Hospital Central South University, Changsha, China, ⁸The First Hospital of Jiaxing, Jiaxing, China, ⁹Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, ¹⁰88 Jiefang Road, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China, ¹¹Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China, ¹²Department of Rheumatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China, ¹³JIANGMEN CENTRAL HOSPITAL, AFFILIATED JIANGMEN HOSPITAL OF SUN YAT-SEN UNIVERSITY, Jiangmen, China, ¹⁴The Second Affiliated Hospital of Guangxi Medical University, Nanning, China, ¹⁵The First Affiliated Hospital of Harbin Medical University, Harbin, China, ¹⁶The Second Affiliated Hospital of Harbin Medical University, Harbin, China, ¹⁷The third hospital of hebei medical university, Shijiazhuang, China, ¹⁸Peace Hospital, Shijiazhuang, China, ¹⁹Henan Province Hospital of TCM, Zhengzhou, China, ²⁰Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China
Background/Purpose: Combination therapy with DMARDs for treating RA is considered as standard of care. However, certain rates of adverse events (AEs) are unavoidable. The stigma…
Abstract Number: 1264 • 2018 ACR/ARHP Annual Meeting
Modeling the Costs and Outcomes Associated with Treatment Sequences, with and without Tofacitinib, for Moderately to Severely Active Psoriatic Arthritis in the US
George Bungey¹, Stacey Chang-Douglass¹, Ming-Ann Hsu², Joseph C Cappelleri², Pamela Young³ and John Woolcott³, ¹Decision Resources Group, London, United Kingdom, ²Pfizer Inc, Groton, CT, ³Pfizer Inc, Collegeville, PA
Background/Purpose: Psoriatic Arthritis (PsA) is a chronic progressive inflammatory condition associated with significant direct and indirect costs. Tofacitinib is an oral Janus kinase inhibitor for…
Abstract Number: 1265 • 2018 ACR/ARHP Annual Meeting
The Challenges of Managing Gout in Primary Care: Results of a Best Practice Audit
Lisa K. Stamp¹, Peter T. Chapman², Ben Hudson³, Greg Hamilton⁴ and Andrea Judd⁵, ¹University of Otago, Christchurch, New Zealand, ²Christchurch Hospital, Christchurch, New Zealand, ³University of Otago, Christchurch, Christchurch, New Zealand, ⁴Canterbury District Health Board, Christchurch, New Zealand, ⁵Kaikoura Medical Centre, Kaikoura, New Zealand
Background/Purpose: The majority of gout management occurs in primary care and may be suboptimal. While community based clinical trials have reported improvements whether such improvements…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].